These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27520326)

  • 21. Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia.
    Patel D; Brown ML; Edwards S; Oster RA; Stripling J
    Int J Antimicrob Agents; 2023 Mar; 61(3):106735. PubMed ID: 36690124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
    Holubar M; Meng L; Deresinski S
    Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
    Yi YH; Wang JL; Yin WJ; Xu WH
    Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
    Johnson TM; Molina KC; Miller MA; Kiser TH; Huang M; Mueller SW
    Int J Antimicrob Agents; 2021 Apr; 57(4):106310. PubMed ID: 33609718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Park HJ; Kim SH; Kim MJ; Lee YM; Park SY; Moon SM; Park KH; Chong YP; Lee SO; Choi SH; Woo JH; Kim YS
    J Infect; 2012 Dec; 65(6):505-12. PubMed ID: 22902942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia.
    Espedido BA; Jensen SO; van Hal SJ
    J Antimicrob Chemother; 2015 Mar; 70(3):797-801. PubMed ID: 25406295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftaroline: Systematic Review of Clinical Uses and Emerging Drug Resistance.
    Abate G; Wang G; Frisby J
    Ann Pharmacother; 2022 Dec; 56(12):1339-1348. PubMed ID: 35300514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future.
    Bavaro DF; Belati A; Bussini L; Cento V; Diella L; Gatti M; Saracino A; Pea F; Viale P; Bartoletti M
    Expert Opin Drug Saf; 2024 Jan; 23(1):9-36. PubMed ID: 38145925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli.
    Morrisette T; Lagnf AM; Alosaimy S; Rybak MJ
    Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2199-2203. PubMed ID: 32535805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence?
    Tremblay S; Lau TT; Ensom MH
    Ann Pharmacother; 2013; 47(7-8):1045-54. PubMed ID: 23715070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience.
    Lipsky BA; Cannon CM; Ramani A; Jandourek A; Calmaggi A; Friedland HD; Goldstein EJ
    Diabetes Metab Res Rev; 2015 May; 31(4):395-401. PubMed ID: 25417910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA).
    Shafiq I; Bulman ZP; Spitznogle SL; Osorio JE; Reilly IS; Lesse AJ; Parameswaran GI; Mergenhagen KA; Tsuji BT
    Infect Dis (Lond); 2017 May; 49(5):410-416. PubMed ID: 28116950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.
    Ruggero MA; Peaper DR; Topal JE
    Infect Dis (Lond); 2015 Jun; 47(6):379-84. PubMed ID: 25746601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftaroline for Suspected or Confirmed Invasive Methicillin-Resistant Staphylococcus aureus: A Pharmacokinetic Case Series.
    Cies JJ; Moore WS; Enache A; Chopra A
    Pediatr Crit Care Med; 2018 Jun; 19(6):e292-e299. PubMed ID: 29419605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
    Poon H; Chang MH; Fung HB
    Clin Ther; 2012 Apr; 34(4):743-65. PubMed ID: 22444785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.
    Barber KE; Rybak MJ; Sakoulas G
    J Antimicrob Chemother; 2015 Jan; 70(1):311-3. PubMed ID: 25125677
    [No Abstract]   [Full Text] [Related]  

  • 37. Physiologically based pharmacokinetic modelling to inform combination dosing regimens of ceftaroline and daptomycin in special populations.
    Martins FS; Martins JES; Severino P; Annaert P; Sy SKB
    Br J Clin Pharmacol; 2023 Sep; 89(9):2726-2738. PubMed ID: 37005335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.
    Fusco NM; Toussaint KA; Prescott WA
    Ann Pharmacother; 2015 Apr; 49(4):458-68. PubMed ID: 25583881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure.
    Cannavino CR; Mendes RE; Sader HS; Farrell DJ; Critchley IA; Biek D; Le J; Skochko SM; Jones RN; Bradley JS
    Pediatr Infect Dis J; 2016 Jul; 35(7):813-5. PubMed ID: 27093165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceftaroline for complicated skin and skin-structure infections.
    Nannini EC; Stryjewski ME; Corey GR
    Expert Opin Pharmacother; 2010 May; 11(7):1197-206. PubMed ID: 20402556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.